286 related articles for article (PubMed ID: 28465867)
21. Hospitalization risk associated with typical and atypical antipsychotic use in community-dwelling elderly patients.
Aparasu RR; Jano E; Johnson ML; Chen H
Am J Geriatr Pharmacother; 2008 Oct; 6(4):198-204. PubMed ID: 19028375
[TBL] [Abstract][Full Text] [Related]
22. New generation antipsychotics for first episode schizophrenia.
Rummel C; Hamann J; Kissling W; Leucht S
Cochrane Database Syst Rev; 2003; (4):CD004410. PubMed ID: 14584012
[TBL] [Abstract][Full Text] [Related]
23. Off-label second generation antipsychotics for impulse regulation disorders: a review.
Scheltema Beduin A; de Haan L
Psychopharmacol Bull; 2010; 43(3):45-81. PubMed ID: 21150846
[TBL] [Abstract][Full Text] [Related]
24. Cost effectiveness of long-acting risperidone injection versus alternative antipsychotic agents in patients with schizophrenia in the USA.
Edwards NC; Locklear JC; Rupnow MF; Diamond RJ
Pharmacoeconomics; 2005; 23 Suppl 1():75-89. PubMed ID: 16416763
[TBL] [Abstract][Full Text] [Related]
25. Medication patterns and costs associated with olanzapine and other atypical antipsychotics in the treatment of bipolar disorder.
Zhu B; Kulkarni PM; Stensland MD; Ascher-Svanum H
Curr Med Res Opin; 2007 Nov; 23(11):2805-14. PubMed ID: 17910804
[TBL] [Abstract][Full Text] [Related]
26. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.
Declercq T; Petrovic M; Azermai M; Vander Stichele R; De Sutter AI; van Driel ML; Christiaens T
Cochrane Database Syst Rev; 2013 Mar; (3):CD007726. PubMed ID: 23543555
[TBL] [Abstract][Full Text] [Related]
27. Diagnoses associated with use of atypical antipsychotics in a commercial health plan: a claims database analysis.
Citrome L; Kalsekar I; Guo Z; Laubmeier K; Hebden T
Clin Ther; 2013 Dec; 35(12):1867-75. PubMed ID: 24119767
[TBL] [Abstract][Full Text] [Related]
28. The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease.
Ballard C; Waite J
Cochrane Database Syst Rev; 2006 Jan; (1):CD003476. PubMed ID: 16437455
[TBL] [Abstract][Full Text] [Related]
29. Electroencephalogram Modifications Associated With Atypical Strict Antipsychotic Monotherapies.
Dias Alves M; Micoulaud-Franchi JA; Simon N; Vion-Dury J
J Clin Psychopharmacol; 2018 Dec; 38(6):555-562. PubMed ID: 30247179
[TBL] [Abstract][Full Text] [Related]
30. Did FDA Decisionmaking Affect Anti-Psychotic Drug Prescribing in Children?: A Time-Trend Analysis.
Wang B; Franklin JM; Eddings W; Landon J; Kesselheim AS
PLoS One; 2016; 11(3):e0152195. PubMed ID: 27032095
[TBL] [Abstract][Full Text] [Related]
31. Comparative Safety Signal Assessment of Hospitalization Associated With the Use of Atypical Antipsychotics.
Yunusa I; Teng C; Karaye IM; Crounse E; Alsahali S; Maleki N
Front Psychiatry; 2022; 13():917351. PubMed ID: 35733796
[TBL] [Abstract][Full Text] [Related]
32. Atypical antipsychotics: mechanism of action.
Seeman P
Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706
[TBL] [Abstract][Full Text] [Related]
33. Prolactin-related adverse events and change in prolactin levels in pediatric patients given antipsychotics for schizophrenia and schizophrenia spectrum disorders: A systematic review.
Druyts E; Zoratti MJ; Toor K; Wu P; Kanji S; Rabheru K; Mills EJ; Thorlund K
BMC Pediatr; 2016 Nov; 16(1):181. PubMed ID: 27825323
[TBL] [Abstract][Full Text] [Related]
34. A model of anticholinergic activity of atypical antipsychotic medications.
Chew ML; Mulsant BH; Pollock BG; Lehman ME; Greenspan A; Kirshner MA; Bies RR; Kapur S; Gharabawi G
Schizophr Res; 2006 Dec; 88(1-3):63-72. PubMed ID: 16928430
[TBL] [Abstract][Full Text] [Related]
35. Comparison of Quetiapine Abuse and Misuse Reports to the FDA Adverse Event Reporting System With Other Second-Generation Antipsychotics.
Evoy KE; Teng C; Encarnacion VG; Frescas B; Hakim J; Saklad S; Frei CR
Subst Abuse; 2019; 13():1178221819844205. PubMed ID: 31068753
[TBL] [Abstract][Full Text] [Related]
36. A Retrospective Cohort Study of Acute Kidney Injury Risk Associated with Antipsychotics.
Jiang Y; McCombs JS; Park SH
CNS Drugs; 2017 Apr; 31(4):319-326. PubMed ID: 28290080
[TBL] [Abstract][Full Text] [Related]
37. Clozapine discrimination with a low training dose distinguishes atypical from typical antipsychotic drugs in rats.
Porter JH; Varvel SA; Vann RE; Philibin SD; Wise LE
Psychopharmacology (Berl); 2000 Apr; 149(2):189-93. PubMed ID: 10805615
[TBL] [Abstract][Full Text] [Related]
38. Comparison of pediatric atypical antipsychotic exposures reported to U.S. poison centers.
Stassinos G; Klein-Schwartz W
Clin Toxicol (Phila); 2017 Jan; 55(1):40-45. PubMed ID: 27644404
[TBL] [Abstract][Full Text] [Related]
39. Priapism associated with conventional and atypical antipsychotic medications: a review.
Compton MT; Miller AH
J Clin Psychiatry; 2001 May; 62(5):362-6. PubMed ID: 11411819
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
